R&D Systems Inc. Tocris Bioscience Boston Biochem

AA 2414

Cat. No. 3025

AA 2414 C22H26O4 [112665-43-7]

Price and Availability

For AA 2414 pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Alternative Name: Seratrodast

Chemical Name: 7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid

Biological Activity

Thromboxane A2 (TP) receptor antagonist. Antiasthmatic agent; inhibits platelet aggregation and bronchoconstriction induced by a TXA2 mimetic in guinea pigs.

Technical Data

M.Wt:
354.44
Formula:
C22H26O4
Solubility:
Soluble to 75 mM in 1.1eq. NaOH and to 100 mM in DMSO
Purity:
>98 %
Storage:
Store at +4°C
CAS No:
112665-43-7

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Safety Data Sheet: View Safety Data Sheet

References

Ashida et al (1989) A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids. Prostaglandins 38 91. PMID: 2748922.

Kurokawa et al (1994) Antagonism of the human thromboxane A2 receptor by an anti-asthmatic agent AA-2414. Biol.Pharm.Bull. 17 383. PMID: 8019502.

Cui et al (2007) Leukotrienes and cyclooxygenase products mediate anaphylactic venoconstriction in ovalbumin sensitized rat livers. Eur.J.Pharmacol. 576 99. PMID: 17706964.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

Keywords: AA 2414, supplier, Thromboxane, A2, TP, receptors, antagonists, TXA2, Prostanoid, prostaglandins, prostacyclins, eicosanoids, AA2414

Quick Order

Find multiple products by catalog number

divider line

Immunology Guide

Immunology Research Guide

Highlights over 150 products for immunology research. Request a copy or view PDF today.

divider line

New Therapies and Challenges in Asthma

Written by Peter J. Barnes

Asthma Poster

'New Therapies, Challenges, and Breakthroughs in Asthma' highlights key pathways and new therapies used to treat asthma, including those currently in clinical development.

divider line

Regulation of Vascular Reactivity by GPCRs

Written by J.J. Maguire and A.P. Davenport

Cardiovascular Poster

'Regulation of Vascular Reactivity by G-protein-coupled Receptors' summarizes the key GPCRs regulating vascular reactivity.

divider line

7-TM Receptor Signaling

Written by T. Kenakin et al

7-TM Poster

'Seven Transmembrane Receptor Signaling' highlights the multiple behaviors of 7-TMs including G-protein-dependent and -independent signaling as well as the concept of collateral efficacy

divider line

New Product Guide

NPG

Highlights over 130 new products added in the second half of 2013. Request a copy or view PDF today.

divider line

New Products in this Area

AS 2034178

Selective FFA1 (GPR40) agonist

(±)-NBI 74330

Potent and selective CXCR3 antagonist

Purmorphamine

Smo receptor agonist

CTCE 9908

CXCR4 antagonist; antitumor

VUF 11207 fumarate

Potent CXCR7 agonist

TC-G 1006

Potent and selective sphingosine-1-phosphate receptor 1 (S1P1) agonist

DMNPE-caged ATP diammonium salt

Caged ATP

MK 1903

Potent and selective GPR109A (HCA2) agonist

M 25

Potent Smoothened (Smo) receptor antagonist

Ki 16425

LPA1 and LPA3 receptor antagonist

CYM 50358 hydrochloride

Potent and selective S1P4 antagonist

(±)-AMG 487

CXCR3 antagonist; inhibits cell migration and metastasis

GW 627368

Selective EP4 receptor competitive antagonist

Sign-up for new product e-alerts
divider line

Tocris Events

Win $1,000 Product Credit

Experimental Biology

Experimental Biology

April 26 - 30, 2014

San Diego CA, USA

Booth Number: 918